ZNTL- Zentalis Pharmaceuticals, Inc.

Name: Zentalis Pharmaceuticals, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Zentalis Pharmaceuticals, Inc. (ZNTL) has 6 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. ZNTL is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
10%	Walters Group	13.51M	$49.58M	-
10%	Matrix Capital Management Company, LP	6.46M	$23.71M	-
Other	Vultaggio Vincent	146.5K	$537.7K	-
Other	Bucher James B	100.0K	$367.0K	-
CEO	Eastland Julia Marie	79.1K	$290.4K	-

Activity

Buys and sells only

Transactions

10 filings · page 4

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 31, 2023	Gallagher Cam81	President	Sell	27,768	$26.27	$729,506.19	-2.9%	-1.7%	-54.0%
May 26, 2023	Bunker Kevin D.78	Chief Scientific Officer	Sell	80,000	$30.02	$2,401,248.00	-84.2%	-16.1%	-62.5%
Feb 14, 2023	Epperly Melissa B,72	Chief Financial Officer	Sell	7,851	$20.13	$158,004.52	-1.0%	+39.7%	-40.4%
Feb 14, 2023	Gallagher Cam81	President	Sell	11,833	$20.09	$237,760.41	-1.2%	+39.7%	-40.4%
Feb 14, 2023	Bunker Kevin D.78	Chief Scientific Officer	Sell	10,307	$20.14	$207,628.94	-0.6%	+39.7%	-40.4%
Feb 6, 2023	Gallagher Cam81	President	Sell	10,000	$22.27	$222,678.49	-1.0%	-0.9%	-47.5%
Jan 17, 2023	Gallagher Cam81	President	Sell	10,000	$24.15	$241,514.70	-1.4%	-19.5%	-44.8%
Jan 5, 2023	Gallagher Cam81	President	Sell	10,000	$21.02	$210,228.19	-1.4%	-17.4%	-27.6%
Nov 15, 2022	Gallagher Cam81	President	Sell	12,500	$22.77	$284,683.10	-1.7%	-10.8%	-48.9%
Nov 8, 2022	Gallagher Cam81	President	Sell	24,874	$23.62	$587,402.98	-2.1%	-6.4%	-57.6%

← PrevPage 4Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC